BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 7649478)

  • 21. The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.
    Ghosh P; Tan TH; Rice NR; Sica A; Young HA
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1696-700. PubMed ID: 8383323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and transcription factor-binding sites of the human c-rel proto-oncogene promoter.
    Viswanathan M; Yu M; Mendoza L; Yunis JJ
    Gene; 1996 May; 170(2):271-6. PubMed ID: 8666258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.
    Klug CA; Gerety SJ; Shah PC; Chen YY; Rice NR; Rosenberg N; Singh H
    Genes Dev; 1994 Mar; 8(6):678-87. PubMed ID: 7926758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells.
    Venkataraman L; Burakoff SJ; Sen R
    J Exp Med; 1995 Mar; 181(3):1091-9. PubMed ID: 7532676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.
    Zheng Y; Ouaaz F; Bruzzo P; Singh V; Gerondakis S; Beg AA
    J Immunol; 2001 Apr; 166(8):4949-57. PubMed ID: 11290773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Rel regulation of the cell cycle in primary mouse B lymphocytes.
    Hsia CY; Cheng S; Owyang AM; Dowdy SF; Liou HC
    Int Immunol; 2002 Aug; 14(8):905-16. PubMed ID: 12147627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participation of the E3-ligase TRIM13 in NF-κB p65 activation and NFAT-dependent activation of c-Rel upon T-cell receptor engagement.
    Hatchi EM; Poalas K; Cordeiro N; N'Debi M; Gavard J; Bidère N
    Int J Biochem Cell Biol; 2014 Sep; 54():217-22. PubMed ID: 25088585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation.
    Gerondakis S; Grumont R; Rourke I; Grossmann M
    Curr Opin Immunol; 1998 Jun; 10(3):353-9. PubMed ID: 9638373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Rel is required for chromatin remodeling across the IL-2 gene promoter.
    Rao S; Gerondakis S; Woltring D; Shannon MF
    J Immunol; 2003 Apr; 170(7):3724-31. PubMed ID: 12646638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner.
    Zelazowski P; Shen Y; Snapper CM
    Int Immunol; 2000 Aug; 12(8):1167-72. PubMed ID: 10917891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
    Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
    J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Rel is essential for B lymphocyte survival and cell cycle progression.
    Tumang JR; Owyang A; Andjelic S; Jin Z; Hardy RR; Liou ML; Liou HC
    Eur J Immunol; 1998 Dec; 28(12):4299-312. PubMed ID: 9862367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ and CD8+ T cell survival is regulated differentially by protein kinase Ctheta, c-Rel, and protein kinase B.
    Saibil SD; Jones RG; Deenick EK; Liadis N; Elford AR; Vainberg MG; Baerg H; Woodgett JR; Gerondakis S; Ohashi PS
    J Immunol; 2007 Mar; 178(5):2932-9. PubMed ID: 17312138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation.
    Wang W; Tam WF; Hughes CC; Rath S; Sen R
    Immunity; 1997 Feb; 6(2):165-74. PubMed ID: 9047238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells.
    Mora A; Youn J; Keegan A; Boothby M
    J Immunol; 2001 Feb; 166(4):2218-27. PubMed ID: 11160275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased c-rel activation contributes to aberrant interleukin-2 expression in CD4(+)T cells of aged rats.
    Gong Z; Liu T; Wan Y; Hang Z; Tong X; Zhang B; Yang H; Zhang X; Zhang L; Jin G
    Mol Immunol; 2014 Sep; 61(1):1-6. PubMed ID: 24853588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching.
    Zelazowski P; Carrasco D; Rosas FR; Moorman MA; Bravo R; Snapper CM
    J Immunol; 1997 Oct; 159(7):3133-9. PubMed ID: 9317110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
    Mercurio F; DiDonato JA; Rosette C; Karin M
    Genes Dev; 1993 Apr; 7(4):705-18. PubMed ID: 8458581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.